Envista Q1 sales $617M, adj. EPS $0.24, maintains 2025 guidance

Envista Holdings Corp

2025-Q1 EPS reported $0.10 revenue$616,900,000

Sales $617M, core sales +0.2% YoY; net income $18M, adjusted net income $42M.
EPS $0.10, adjusted EPS $0.24 (ahead of expectations); adj. EBITDA $79M (12.8% margin).
Operating cash flow $0M, free cash flow ($5)M vs $29M last year; repurchased 1.1M shares for $19M.
Maintains FY2025 outlook: core sales growth 1-3%, adj. EPS $0.95-$1.05, adj. EBITDA margin ≈14%.
Growth in Consumables, Nobel Biocare, Spark; soft Diagnostics; China ortho down due to VBP preparations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.